M.D., FCAP, Chief Medical Officer, Color Genomics
Most recently, Hagenkord served as senior vice president of medical strategy for InVitae Corporation, a genetics information company, where her role included serving as medical director, contributing to corporate strategy, acting as commercial liaison, and leading the company’s physician education programs. Hagenkord is a board-certified molecular genetic pathologist. Prior to joining Invitae, Jill served as chief medical officer and senior vice president at Complete Genomics, Inc. Her other prior experiences include founder and chief medical officer for iKaryos Diagnostics, associate professor of pathology at Creighton University School of Medicine, director of molecular pathology and clinical genomics at Creighton Medical Laboratories, and pathologist at Deltagen, Inc. Hagenkord received her M.D. from Stanford University School of Medicine in 1999, did her residency training in pathology at the University of California at San Francisco and the University of Iowa, and completed fellowships in pathology/oncology informatics and molecular genetic pathology at the University of Pittsburgh Medical Center.
Session Abstract – PMWC 2017 Silicon Valley
Session Synopsis: This session will explore how individuals will increasingly participate in personalized medicine and their own health care, from improved wellness to managing their personal heath data to partnering with researchers and physicians.